600538.SS

Basic Materials Agricultural Inputs

Beihai Gofar Chuanshan Biological Co., Ltd.

CN¥4.76
-0.03 -0.63% today

Price History

Not enough data

Key Stats

Market Cap
2.50B
Avg Volume
11.54M
EPS
-CN¥0.18
52W High
CN¥7.70
52W Low
CN¥4.19
Div. Yield
0.0%

Valuation

P/B Ratio
3.69
P/S Ratio
7.47
EV/EBITDA
-256.08
EV/Revenue
7.36

Margins

Gross Margin 21.0%
Operating Margin (3.3%)
Net Margin (27.9%)
EBITDA Margin (2.9%)

Growth & Returns

Revenue Growth (YoY)
2.4%
Return on Equity
(12.5%)
Return on Assets
(1.5%)

Liquidity & Leverage

Current Ratio
4.15
Quick Ratio
3.36
Debt / Equity
0.10
Total Cash
136.60M
Total Debt
69.20M

About

Beihai Gofar Chuanshan Biological Co., Ltd., together with its subsidiaries, distributes pharmaceutical products in China. It operates through Pharmaceutical Distribution; Pharmaceutical Manufacturing; DNA Testing Equipment, Consumables and Testing Services; and Others segments. The company wholesales and retails pharmaceutical products through hospitals, clinics, other medical institutions, pharmacies, health centers, clinics, directly operated stores, general agents, distributors, and allocations. It also provides pearl eye drops, pearl powder, and pearl layer powder under the Haibao brand; brand gastrointestinal granules, honeysuckle oral solution, and children's syrup under the Guofa brand; and traumatic injury medicated wine, and sea snake medicated wine under the Haima brand. In addition, the company produces and sells forensic DNA testing equipment, reagents, and consumables; and provides technical services, including DNA testing services. Further, it engages in culture and arts activities; and provision of technical services. The company was formerly known as Beihai Gofar Marine Biological Industry Co., Ltd. and changed its name to Beihai Gofar Chuanshan Biological Co., Ltd. in June 2021. Beihai Gofar Chuanshan Biological Co., Ltd. was incorporated in 1993 and is headquartered in Beihai, China.

www.gofar.com.cn